Federal contract award
W911QY25C0015
BROAD AGENCY ANNOUNCEMENT TO HAVE STABLE DRY FORMULATION OF A SAFE PHAGE PREPARATION THAT POSSESSES STRONG ANTIMICROBIAL EFFICACY AGAINST FOODBORNE BACTERIAL PATHOGENS OF CONCERN TO THE US ARMY, SUCH AS L. MONOCYTOGENES, SALMONELLA, AND E.COLI STEC.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG NATICK |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AC32 — NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $178.8K |
| Current contract value | $178.8K |
| Potential contract value / ceiling | $250.0K |
| Start date | Feb 13, 2025 |
| Current end date | Feb 19, 2029 |
| Potential end date | Feb 19, 2029 |
| Latest award activity | Dec 16, 2025 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 16, 2025 | P00004 | $99.0K | OPTIMIZE THE DEVELOPMENT AND TEST DRY FORMULATION OF THE PHAGESAFE PHAGE PREPARATION THAT HAS POTENT ANTIMICROBIAL ACTIVITY AGAINST THREE MAJOR FOODBORNE BACTERIAL PATHOGENS. 831 AUTHORITY. |
| May 8, 2025 | P00003 | $0 | OPTIMIZE THE DEVELOPMENT AND TEST DRY FORMULATION OF THE PHAGESAFE PHAGE PREPARATION THAT HAS POTENT ANTIMICROBIAL ACTIVITY AGAINST THREE MAJOR FOODBORNE BACTERIAL PATHOGENS. |
| Apr 29, 2025 | P00002 | $0 | OPTIMIZE THE DEVELOPMENT AND TEST DRY FORMULATION OF THE PHAGESAFE PHAGE PREPARATION THAT HAS POTENT ANTIMICROBIAL ACTIVITY AGAINST THREE MAJOR FOODBORNE BACTERIAL PATHOGENS. |
| Apr 22, 2025 | P00001 | $0 | OPTIMIZE THE DEVELOPMENT AND TEST DRY FORMULATION OF THE PHAGESAFE PHAGE PREPARATION THAT HAS POTENT ANTIMICROBIAL ACTIVITY AGAINST THREE MAJOR FOODBORNE BACTERIAL PATHOGENS. |
| Feb 13, 2025 | 0 | $79.8K | BROAD AGENCY ANNOUNCEMENT TO HAVE STABLE DRY FORMULATION OF A SAFE PHAGE PREPARATION THAT POSSESSES STRONG ANTIMICROBIAL EFFICACY AGAINST FOODBORNE BACTERIAL PATHOGENS OF CONCERN TO THE US ARMY, SUCH AS L. MONOCYTOGENES, SALMONELLA, AND E.COLI STEC. |
Estimated positioning window
Feb 19, 2028 – Aug 19, 2028
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2029-02-19 (848 days from calculation)
- +15 points
- 1 historical awards in this buyer and category group
- +0 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2025-12-16
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.